retatrutide clinical trials sign up Eli Lilly infiltrates anti-obesity market as Phase III trial for begins Retatrutide for weight loss: Study

Weight loss can vary widely among individuals, but many people lose between 5% to 10% of their body weight over six months to a year

In late 2024, the Biden administration proposed Medicare coverage of anti-obesity medications, and in November 2025, Medicare announced it will begin covering weight-loss drugs like Wegovy and Mounjaro

These actions also present serious patient safety concerns by flooding the market with drugs that have not been reviewed by the FDA for safety, effectiveness and quality

Liquids that are not considered clear are red sports drinks, red popsicles, grape juice, orange juice, red jello, and yogurt